Literature DB >> 35773606

Risk of recurrence after local resection of T1 rectal cancer: a meta-analysis with meta-regression.

Nik Dekkers1, Hao Dang2, Jolein van der Kraan2, Saskia le Cessie3, Philip P Oldenburg2, Jan W Schoones4, Alexandra M J Langers2, Monique E van Leerdam2, Jeanin E van Hooft2, Yara Backes5, Katarina Levic6, Alexander Meining7, Giorgio M Saracco8, Fabian A Holman9, Koen C M J Peeters9, Leon M G Moons5, Pascal G Doornebosch10, James C H Hardwick2, Jurjen J Boonstra2.   

Abstract

BACKGROUND: T1 rectal cancer (RC) patients are increasingly being treated by local resection alone but uniform surveillance strategies thereafter are lacking. To determine whether different local resection techniques influence the risk of recurrence and cancer-related mortality, a meta-analysis was performed.
METHODS: A systematic search was conducted for T1RC patients treated with local surgical resection. The primary outcome was the risk of RC recurrence and RC-related mortality. Pooled estimates were calculated using mixed-effect logistic regression. We also systematically searched and evaluated endoscopically treated T1RC patients in a similar manner.
RESULTS: In 2585 unique T1RC patients (86 studies) undergoing local surgical resection, the overall pooled cumulative incidence of recurrence was 9.1% (302 events, 95% CI 7.3-11.4%; I2 = 68.3%). In meta-regression, the recurrence risk was associated with histological risk status (p < 0.005; low-risk 6.6%, 95% CI 4.4-9.7% vs. high-risk 28.2%, 95% CI 19-39.7%) and local surgical resection technique (p < 0.005; TEM/TAMIS 7.7%, 95% CI 5.3-11.0% vs. other local surgical excisions 10.8%, 95% CI 6.7-16.8%). In 641 unique T1RC patients treated with flexible endoscopic excision (16 studies), the risk of recurrence (7.7%, 95% CI 5.2-11.2%), cancer-related mortality (2.3%, 95% CI 1.1-4.9), and cancer-related mortality among patients with recurrence (30.0%, 95% CI 14.7-49.4%) were comparable to outcomes after TEM/TAMIS (risk of recurrence 7.7%, 95% CI 5.3-11.0%, cancer-related mortality 2.8%, 95% CI 1.2-6.2% and among patients with recurrence 35.6%, 95% CI 21.9-51.2%).
CONCLUSIONS: Patients with T1 rectal cancer may have a significantly lower recurrence risk after TEM/TAMIS compared to other local surgical resection techniques. After TEM/TAMIS and endoscopic resection the recurrence risk, cancer-related mortality and cancer-related mortality among patients with recurrence were comparable. Recurrence was mainly dependent on histological risk status.
© 2022. The Author(s).

Entities:  

Keywords:  Follow-up; Local surgical resection; Recurrence; T1 rectal cancer; Therapeutic endoscopy

Year:  2022        PMID: 35773606     DOI: 10.1007/s00464-022-09396-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  95 in total

1.  Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data.

Authors:  Theo Stijnen; Taye H Hamza; Pinar Ozdemir
Journal:  Stat Med       Date:  2010-12-20       Impact factor: 2.373

2.  Morbidity risk factors after low anterior resection with total mesorectal excision and coloanal anastomosis: a retrospective series of 483 patients.

Authors:  Malika Bennis; Yann Parc; Jérémie H Lefevre; Najim Chafai; Emmanuel Attal; Emmanuel Tiret
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

Review 3.  Colorectal cancer.

Authors:  Evelien Dekker; Pieter J Tanis; Jasper L A Vleugels; Pashtoon M Kasi; Michael B Wallace
Journal:  Lancet       Date:  2019-10-19       Impact factor: 79.321

4.  Quality-of-life impairment after endoluminal locoregional resection and laparoscopic total mesorectal excision.

Authors:  Emanuele Lezoche; Alessandro M Paganini; Bernardina Fabiani; Andrea Balla; Annarita Vestri; Lorenzo Pescatori; Daniele Scoglio; Giancarlo D'Ambrosio; Giovanni Lezoche
Journal:  Surg Endosc       Date:  2013-09-04       Impact factor: 4.584

Review 5.  Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions.

Authors:  Steven L Bosch; Steven Teerenstra; Johannes H W de Wilt; Chris Cunningham; Iris D Nagtegaal
Journal:  Endoscopy       Date:  2013-07-24       Impact factor: 10.093

6.  Evaluation of a Completion Total Mesorectal Excision in Patients After Local Excision of Rectal Cancer: A Word of Caution.

Authors:  Julia T van Groningen; Pieter van Hagen; Rob A E M Tollenaar; Jurriaan B Tuynman; Perla J Marang-van de Mheen; Pascal G Doornebosch; Pieter J Tanis; Eelco J R de Graaf
Journal:  J Natl Compr Canc Netw       Date:  2018-07       Impact factor: 11.908

7.  Risk and Time Pattern of Recurrences After Local Endoscopic Resection of T1 Colorectal Cancer: A Meta-analysis.

Authors:  Hao Dang; Nik Dekkers; Saskia le Cessie; Jeanin E van Hooft; Monique E van Leerdam; Philip P Oldenburg; Louis Flothuis; Jan W Schoones; Alexandra M J Langers; James C H Hardwick; Jolein van der Kraan; Jurjen J Boonstra
Journal:  Clin Gastroenterol Hepatol       Date:  2020-12-01       Impact factor: 11.382

8.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.

Authors:  Yojiro Hashiguchi; Kei Muro; Yutaka Saito; Yoshinori Ito; Yoichi Ajioka; Tetsuya Hamaguchi; Kiyoshi Hasegawa; Kinichi Hotta; Hideyuki Ishida; Megumi Ishiguro; Soichiro Ishihara; Yukihide Kanemitsu; Yusuke Kinugasa; Keiko Murofushi; Takako Eguchi Nakajima; Shiro Oka; Toshiaki Tanaka; Hiroya Taniguchi; Akihito Tsuji; Keisuke Uehara; Hideki Ueno; Takeharu Yamanaka; Kentaro Yamazaki; Masahiro Yoshida; Takayuki Yoshino; Michio Itabashi; Kentaro Sakamaki; Keiji Sano; Yasuhiro Shimada; Shinji Tanaka; Hiroyuki Uetake; Shigeki Yamaguchi; Naohiko Yamaguchi; Hirotoshi Kobayashi; Keiji Matsuda; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2019-06-15       Impact factor: 3.402

9.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.

Authors:  Matthew J Page; Joanne E McKenzie; Patrick M Bossuyt; Isabelle Boutron; Tammy C Hoffmann; Cynthia D Mulrow; Larissa Shamseer; Jennifer M Tetzlaff; Elie A Akl; Sue E Brennan; Roger Chou; Julie Glanville; Jeremy M Grimshaw; Asbjørn Hróbjartsson; Manoj M Lalu; Tianjing Li; Elizabeth W Loder; Evan Mayo-Wilson; Steve McDonald; Luke A McGuinness; Lesley A Stewart; James Thomas; Andrea C Tricco; Vivian A Welch; Penny Whiting; David Moher
Journal:  Syst Rev       Date:  2021-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.